Caleb Rans, PharmD

Contributing Writer https://www.hematologyadvisor.com

Caleb Rans is a clinical pharmacist and medical communications specialist with professional expertise in medical writing, editing, and contract clinical research. He holds a PharmD from the University of Alberta and presently resides in Vancouver, Canada. He currently works as an independent consultant for several news, CME, and pharmaceutical companies.

All articles by Caleb Rans, PharmD

A doctor shows a tablet to an elderly patient

Lymphoma

Current and Prospective Treatment Options for Waldenström Macroglobulinemia

Caleb Rans, PharmD

February 7, 2020

Researchers discussed diagnostic considerations, indications for therapy, and treatment options for patients with Waldenström macroglobulinemia.

General Hematology

Personalizing Intensive Therapy for Older Patients With Hematologic Cancers

Caleb Rans, PharmD

January 29, 2020

Several factors need to be considered when choosing optimal therapy for older patients with hematologic malignancies, particularly when it comes to managing toxicity.

General Hematology

British Society of Hematology Guideline Update for Point-of-Care Testing in Hematology

Caleb Rans, PharmD

November 27, 2019

Researchers reviewed currently available point-of-care technology and provided recommendations for standardizing use of this technology.

Researchers assessed 266 pregnant women with and without sickle cell disease in Ghana.

Thrombotic Disorders

Treating Venous Thromboembolism in Patients With Cancer: 2019 Clinical Practice Guidelines

Caleb Rans, PharmD

November 12, 2019

This 2019 guideline update includes a review of new data on anticoagulant use and risk stratification in venous thromboembolism.

Lymphoma

Determining Prognosis for Patients With Diffuse Large B-Cell Lymphoma

Caleb Rans, PharmD

October 23, 2019

Researchers summarized the novel techniques and models currently being developed to improve prognostication in diffuse large B-cell lymphoma.

A clinician observes the results of a genetic test on their tablet.

Bleeding Disorders

Advances in the Diagnosis of Type 1 von Willebrand Disease: Genetic Testing

Caleb Rans, PharmD

October 9, 2019

Despite the increasing availability of gene sequencing, several barriers prevent it from having utility as a tool for diagnosis of type 1 von Willebrand disease.